Clinical Trial Update: Single and Repeat Doses of DMT in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating single and repeat doses of DMT in healthy subjects, sponsored by Algernon Pharmaceuticals, with stroke listed as the related con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DMT (N,N-Dimethyltryptamine)

Snippet

Sponsor: Algernon Pharmaceuticals | Conditions: Stroke | Phase 1 | Status: ACTIVE_NOT_RECRUITING